Results 61 to 70 of about 503,079 (239)
A schematic illustrating the fabrication process and ferroptosis‐mediated therapeutic mechanism of carrier‐free self‐assembled BBR/NC‐SAPs for overcoming bortezomib resistance in multiple myeloma. ABSTRACT Therapeutic relapse driven by bortezomib resistance represents a formidable clinical barrier in the management of multiple myeloma (MM).
Yiwen Lv +16 more
wiley +1 more source
Thyrotoxic Periodic Paralysis: Case Reports and an Up-to-Date Review of the Literature
Objectives. To describe 2 cases of thyrotoxic periodic paralysis. Methods. We report of 2 cases of thyrotoxic periodic paralysis in 2 individuals from 2 different backgrounds with emphasis on their presentation and treatment.
Abbi Lulsegged +2 more
doaj +1 more source
Hypokalaemic Periodic Paralysis in a Patient with Subclinical Hyperthyroidism: A Rare Case [PDF]
Thyrotoxic Periodic Paralysis (TPP) is an uncommon disorder. Though many cases of hypokalaemic periodic paralysis are reported in overt hyperthyroidism , hypokalaemic paralysis in subclinical hyperthyroidism is very rare. Subclinical hyperthyroidism is
Swati Hegde +2 more
doaj +1 more source
A disease‐stage synchronized nanozyme platform is developed to treat polymicrobial sepsis by adapting its functions to changing infection environments. The system eliminates multidrug‐resistant bacteria during early infection while reducing inflammation and restoring immune balance during recovery, providing an integrated strategy for infection control
Anlai Zou +11 more
wiley +1 more source
Thyrotoxic periodic paralysis: A case report
The paper presented two cases of periodic paralysis complicating Graves' disease of the Indonesians. Clinical presentation and laboratory findings were concomitant with classical description of thyrotoxic paralysis in these cases.
Ahmad H Asdie, Ahmad H Asdie
core +1 more source
Paralysis Periodica Paramyotonica Caused by SCN4A Arg1448Cys Mutation
Paralysis periodica paramyotonica is an overlapping disease that shares the features of paramyotonia characteristic of paramyotonia congenita (PC) and periodic paralysis characteristic of hyperkalemic periodic paralysis.
Wei-Chih Hsu +5 more
doaj +1 more source
Photobiomodulated microglia release engineered extracellular vesicles that deliver UFL1 to the injured spinal cord. UFL1 competitively binds p53 with MDM2, inhibiting p53 ubiquitination and stabilizing p53 signaling. This dual mechanism simultaneously promotes anti‐inflammatory microglial polarization and directs neural stem cell differentiation toward
Yunxiao Fang +12 more
wiley +1 more source
During pancreatitis, IL‐1α is released from necrotic acinar cells. In response to IL‐1α, pancreatic fibroblasts release chemokines and cytokines that regulate the recruitment of immune cells to the damaged organ. Furthermore, IL‐1α primes fibroblasts, resulting in increased tissue fibrosis during chronic pancreatitis.
Hala Mazloum +13 more
wiley +1 more source
Thyrotoxic periodic paralysis (TPP) is more commonly seen in Graves’ disease. But TPP can occur in any condition leading to a hyperthyroid state. It’s important to identify the underlying aetiology of the thyrotoxic state as the management differs with ...
M. S. N. Padmasiri +4 more
doaj +1 more source
A new class of lysosome‐directed molecular glue degraders selectively enhance CAPRIN1–APP interactions, driving APP degradation and reducing amyloid‐β production in human neurons and Alzheimer's disease mouse models. This CAPRIN1‐dependent targeted protein degradation strategy reveals a previously unrecognized therapeutic approach for disrupting the ...
Sunghan Jung +15 more
wiley +1 more source

